China Biologic Products, Inc., a company based on blood plasma products, entered an R&D agreement with the Institute of Blood Transfusion of Chengdu, Sichuan Province. IBT is a division of the Chinese Academy of Medical Sciences and Peking Union Medical College. For China Biologic, the alliance will serve to strengthen its R&D capabilities and manufacturing processes. More details...

Stock Symbol: (OTCBB: CBPO)